skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 61 - 80 of 8,822  for All Library Resources

previous page 1 2 3 Results 4 5 next page
Refined by: resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
61
FDA Accepts Bristol-Myers' Mavacamten Application In Inherited Heart Disease For Review
Material Type:
Newsletter Article
Add to My Research

FDA Accepts Bristol-Myers' Mavacamten Application In Inherited Heart Disease For Review

Benzinga Newswires, 2021

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

62
Bristol Myers: FDA to Review Mavacamten in Hypertrophic Cardiomyopathy BMY
Material Type:
Newsletter Article
Add to My Research

Bristol Myers: FDA to Review Mavacamten in Hypertrophic Cardiomyopathy BMY

Dow Jones Institutional News, 2021

Copyright Dow Jones & Company Inc Mar 19, 2021

Digital Resources/Online E-Resources

63
Clinical Trial: Bern Cardiac Amyloidosis REgistry (B-CARE)
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Bern Cardiac Amyloidosis REgistry (B-CARE)

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Mar 3, 2021

Digital Resources/Online E-Resources

64
Clinical Trial: Unmasking the Prevalence of AC in an Unselected Echocardiographic Population
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Unmasking the Prevalence of AC in an Unselected Echocardiographic Population

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Feb 5, 2021

Digital Resources/Online E-Resources

65
Clinical Trial: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Jan 13, 2021

Digital Resources/Online E-Resources

66
Cytokinetics Gets FDA Orphan Designation for Hypertrophic Cardiomyopathy Treatment
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Gets FDA Orphan Designation for Hypertrophic Cardiomyopathy Treatment

Dow Jones Institutional News, 2021

Copyright Dow Jones & Company Inc Jan 11, 2021

Digital Resources/Online E-Resources

67
Clinical Trial: Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Nov 21, 2020

Digital Resources/Online E-Resources

68
MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten
Material Type:
Newsletter Article
Add to My Research

MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten

News Bites US - NASDAQ, 2020

Copyright News Bites Pty Ltd Nov 20, 2020

Digital Resources/Online E-Resources

69
Case Reports Journal Issues Research Articles in Nov. 1, 2020 Edition
Material Type:
Newsletter Article
Add to My Research

Case Reports Journal Issues Research Articles in Nov. 1, 2020 Edition

Targeted News Service, 2020

Targeted News Service

Digital Resources/Online E-Resources

70
Clinical Trial: The Heart Hive - Cardiomyopathy Study
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: The Heart Hive - Cardiomyopathy Study

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Nov 3, 2020

Digital Resources/Online E-Resources

71
Clinical Trial: Retrospective Study of Patients Long-Term Survival of Obstructive Hypertrophis Cardiomyopathy (HCM)
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Retrospective Study of Patients Long-Term Survival of Obstructive Hypertrophis Cardiomyopathy (HCM)

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Oct 28, 2020

Digital Resources/Online E-Resources

72
Clinical Trial: C-MRI Guidance of Implantable CRT-implantation in Non-ischemic Dilated Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: C-MRI Guidance of Implantable CRT-implantation in Non-ischemic Dilated Cardiomyopathy

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Sep 23, 2020

Digital Resources/Online E-Resources

73
Clinical Trial: A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Aug 21, 2020

Digital Resources/Online E-Resources

74
Cytokinetics Working With HCM Registry to Improve Predictive Measures For Hypertrophic Cardiomyopathy Risks
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Working With HCM Registry to Improve Predictive Measures For Hypertrophic Cardiomyopathy Risks

Live Briefs US, 2020

Copyright MT Newswires Aug 18, 2020

Digital Resources/Online E-Resources

75
Clinical Trial: ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Aug 15, 2020

Digital Resources/Online E-Resources

76
Clinical Trial: Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Aug 15, 2020

Digital Resources/Online E-Resources

77
MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten
Material Type:
Newsletter Article
Add to My Research

MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten

News Bites US - NASDAQ, 2020

Copyright News Bites Pty Ltd Aug 4, 2020

Digital Resources/Online E-Resources

78
MyoKardia Doses First Patient in Phase 3 Study of Potential Drug for Obstructive Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

MyoKardia Doses First Patient in Phase 3 Study of Potential Drug for Obstructive Hypertrophic Cardiomyopathy

Live Briefs US, 2020

Copyright MT Newswires Aug 3, 2020

Digital Resources/Online E-Resources

79
Clinical Trial: Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Jul 21, 2020

Digital Resources/Online E-Resources

80
Clinical Trial: Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy

US Fed News Service, Including US State News, 2020

Copyright HT Digital Streams Limited Jul 15, 2020

Digital Resources/Online E-Resources

Results 61 - 80 of 8,822  for All Library Resources

previous page 1 2 3 Results 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2001  (8)
  2. 2001 To 2005  (22)
  3. 2006 To 2010  (226)
  4. 2011 To 2016  (877)
  5. After 2016  (7,690)
  6. More options open sub menu

Subject 

  1. Cardiomyopathy  (8,816)
  2. Clinical Trials  (2,629)
  3. Heart Failure  (2,440)
  4. Patients  (1,842)
  5. Biotechnology Industry  (1,687)
  6. Disease  (1,328)
  7. Webcasting  (1,310)
  8. Stockholders  (1,279)
  9. R&d  (1,249)
  10. Research & Development  (1,249)
  11. Heart  (1,208)
  12. Net Losses  (1,123)
  13. Cardiovascular Disease  (1,116)
  14. Earnings Per Share  (1,113)
  15. Drug Dosages  (1,104)
  16. Diabetes  (1,036)
  17. Cardiology  (1,009)
  18. Fda Approval  (1,005)
  19. Collaboration  (982)
  20. Gene Therapy  (965)
  21. More options open sub menu

Databases 

  1. ProQuest Central  (8,821)
  2. MEDLINE  (1)
  3. More options open sub menu

Language 

  1. English  (8,821)
  2. Urdu  (1)
  3. Arabic  (1)
  4. Spanish  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait